2024 Cancer Research Institute (CRI) Irvington Postdoctoral Fellowship to Promote Racial Diversity


Descriptions

Opportunity type:

Postdoctoral Funding

Sponsor:

Cancer Research Institute

Award amount and duration:

$228,000 over three years

Currency:

USD

Eligibility

Type:
Postdoc
  • The CRI Irvington Postdoctoral Fellowship to Promote Racial Diversity is open to candidates who identify as Black or African American, Hispanic or Latino, American Indian or Alaska Native, Native Hawaiian, or other Pacific Islander. CRI also recognizes that underrepresentation can vary from setting to setting; individuals from socioeconomically disadvantaged populations and from other racial or ethnic groups that can be demonstrated convincingly to be underrepresented by the grantee institution are encouraged to apply. Both U.S. and non-U.S. citizens are eligible.
  • To be eligible, an applicant must be working at a nonprofit institution in the United States or abroad. 
  • Applicants must be working in areas directly related to immunology or cancer immunology. An eligible project must fall into the broad field of immunology with relevance to solving the cancer problem.
  • Applicants must have a doctoral degree by the date of award activation and must conduct their proposed research under a sponsor who holds a formal appointment as an assistant professor or higher rank at the host institution.
  • Applicants with 5 or more years of relevant postdoctoral experience at the time of award activation are not eligible, with the exception of M.D. applicants, who should not include years of residency in this calculation.
  • Only in exceptional circumstances will applicants who have already spent 3 or more years in a sponsor’s laboratory by the start date of fellowship be considered for a fellowship award.
  • The fellowship can be performed in the United States or abroad but must take place at a non-profit institution. There are no citizenship restrictions.
  • Only one fellow per sponsor may apply per application round, and faculty sponsors may not have more than three CRI-supported fellows at any time.
  • Resubmissions: Applicants are permitted to resubmit their fellowship application at a subsequent deadline provided that the new application is improved to reflect progress. Changes to the application should be

Summary

The CRI Irvington Postdoctoral Fellowship to Promote Racial Diversity supports qualified young scientists from underrepresented minorities at leading universities and research centers around the world who wish to receive training in fundamental immunology and cancer immunology. Fellows train under the guidance of a world-renowned immunologist, who sponsors the fellow and prepares him or her for a productive and successful career in cancer immunology. The program will provide additional support for mentoring and career advancement to these individuals, as we work to build a more racially diverse and inclusive community of scientists working in immuno-oncology.

We invite applications from candidates who identify as Black or African American, Hispanic or Latino, or American Indian or Alaska Native, Native Hawaiian, or other Pacific Islander. CRI also recognizes that underrepresentation can vary from setting to setting; individuals from socioeconomically disadvantaged populations and from other racial or ethnic groups that can be demonstrated convincingly to be underrepresented by the grantee institution are encouraged to apply. Both U.S. and non-U.S. citizens are eligible.

CRI seeks hypothesis-driven, mechanistic studies in both immunology and tumor immunology that aim to directly impact our understanding of the immune system’s role in cancer.

A panel of scientists drawn from the CRI Scientific Advisory Council will rigorously evaluate each candidate, the intended sponsor and training environment, and the nature and feasibility of the proposed project.

Newly awarded fellowships provide a stipend of $74,000 for the first year, $76,000 for the second year, and $78,000 for the third year. An allowance of $5,000 per year is allotted to the host institution for use at the sponsor’s discretion to help pay for the fellow’s research supplies, travel to scientific meetings, health insurance, and/or childcare. 

Overhead

Deductions for administrative overhead are not allowed from either the stipend or the institutional allowance. Payments are made monthly in U.S. currency to the host institution.


Deadlines

Application deadlines

RSO detailed review deadline

Date:
February 15, 2024 - 12:00 PM

RSO final internal review deadline

Date:
February 27, 2024 - 12:00 PM

Program application deadline

Date:
March 1, 2024 - 3:00 PM

Approvals

NOTE: Consult your Faculty Associate Dean (Research) (ADR) regarding Faculty-specific deadlines and submission processes.

Principal Investigators: Complete a Research Management System (RMS) record, including a copy of your complete application, and submit this for approvals in RMS.

Postdocs, students, and trainees: For fellowships and externally-sponsored research training awards or opportunities, you must complete the Research Funding Application Approval (RFAA) Trainee PDF form, and submit it, along with a complete copy of the application, to Research Services at rsotrainee@ucalgary.ca. Trainees should not use RMS at this time.

Approvals: The University of Calgary requires that all funding applications be approved prior to submission. Approval requires signatures via either RMS or the RFAA Trainee form, in the following order:

  • Principal Investigator
  • Department Head
  • Faculty ADR/Dean
  • Research Services (on behalf of the Vice-President Research)

Read the Meaning of Grant Signatures policy to understand what your approval means. Please see the agency guidelines for details about which signatures are required on your application, as it may differ from internal requirements.

Late submissions: Late submissions will only be accepted in cases of medical or family emergencies, or other exceptional circumstances. If you submit your RMS record to Research Services after the internal deadline has passed, you must secure additional approvals. Please read: Late Applications Process.



Contact Details


Keywords

Cancer Research Institute (CRI)
Cancer
Postdoctoral
Oncology
Immunology
Equity, diversity, and inclusion (EDI)